We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.14B
AUM Growth
+$116M
Cap. Flow
-$26.7M
Cap. Flow %
-1.25%
Top 10 Hldgs %
33.75%
Holding
461
New
36
Increased
115
Reduced
195
Closed
23

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$4.94M
2
STM icon
STMicroelectronics
STM
+$4.34M
3
FROG icon
JFrog
FROG
+$3.94M
4
MO icon
Altria Group
MO
+$3.73M
5
IDN icon
Intellicheck
IDN
+$3.01M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$9.49M
2
AAPL icon
Apple
AAPL
+$9.19M
3
GM icon
General Motors
GM
+$5.02M
4
GS icon
Goldman Sachs
GS
+$4.66M
5
CSCO icon
Cisco
CSCO
+$3.79M

Sector Composition

Rank Sector Weight
1 Healthcare 22.27%
2 Technology 14.4%
3 Financials 13.66%
4 Energy 11.86%
5 Industrials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OC icon
326
Owens Corning
OC
$11.2B
$365K 0.02%
3,965
-100
-2% -$8.38K
LHX icon
327
L3Harris
LHX
$51.6B
$364K 0.02%
1,794
+40
+2% +$7.5K
GAN
328
DELISTED
GAN Ltd
GAN
$363K 0.02%
19,950
-57,926
-74% -$1.47M
GILD icon
329
CALL
Gilead Sciences
GILD
$162B
$362K 0.02%
5,600
+4,100
+273% +$264K
MAA icon
330
Mid-America Apartment Communities
MAA
$15.4B
$361K 0.02%
2,500
LSXMK
331
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$361K 0.02%
+10,560
New +$354K
EGP icon
332
EastGroup Properties
EGP
$11.2B
$358K 0.02%
2,500
GTE icon
333
Gran Tierra Energy
GTE
$265M
$351K 0.02%
50,101
-473,172
-90% -$3.39M
CI icon
334
Cigna
CI
$73.7B
$349K 0.02%
1,445
CVNA icon
335
Carvana
CVNA
$68.6B
$348K 0.02%
6,635
-780
-11% -$43K
TRP icon
336
TC Energy
TRP
$70.2B
$348K 0.02%
7,615
+1,315
+21% +$58.3K
GILD icon
337
Gilead Sciences
GILD
$162B
$345K 0.02%
5,344
-203
-4% -$13.1K
BX icon
338
Blackstone
BX
$102B
$342K 0.02%
4,584
+429
+10% +$29.6K
FISV
339
Fiserv Inc
FISV
$28.8B
$342K 0.02%
2,871
+468
+19% +$53.7K
BG icon
340
Bunge Global
BG
$20.4B
$341K 0.02%
4,300
-2,650
-38% -$197K
CTVA icon
341
Corteva
CTVA
$52.6B
$335K 0.02%
7,187
-16
-0.2% -$708
SLB icon
342
SLB Ltd
SLB
$73.6B
$335K 0.02%
12,316
-2,520
-17% -$66.3K
WNS
343
DELISTED
WNS Holdings
WNS
$334K 0.02%
4,613
+96
+2% +$7.01K
TFX icon
344
Teleflex
TFX
$6.05B
$330K 0.02%
794
+32
+4% +$12.8K
EPD icon
345
Enterprise Products Partners
EPD
$82.3B
$326K 0.02%
14,808
+44
+0.3% +$967
LH icon
346
Labcorp
LH
$25B
$325K 0.02%
1,482
-17
-1% -$3.41K
CLX icon
347
Clorox
CLX
$11.6B
$323K 0.02%
1,674
NKE icon
348
Nike
NKE
$61.9B
$323K 0.02%
2,429
+32
+1% +$4.45K
BALL icon
349
Ball Corp
BALL
$17.3B
$322K 0.02%
3,795
-7
-0.2% -$613
SYY icon
350
Sysco
SYY
$40.8B
$321K 0.02%
4,082
+30
+0.7% +$2.33K

Similar funds

Ingalls & Snyder LLC's Q1 2021 Portfolio in Review

As of Q1 2021, Ingalls & Snyder LLC held 461 positions worth $2.14B, up 5.8% from $2.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ingalls & Snyder LLC's Q1 2021 filing shows 36 new, 115 increased, 195 reduced and 23 closed positions. Its largest new stake was JFrog: 68,342 shares worth $3.03M. The largest sale was Corcept Therapeutics, an estimated $9.49M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Ingalls & Snyder LLC's largest Q1 2021 buy was JFrog: 68,342 shares worth $3.03M.
  • Ingalls & Snyder LLC added most to Deere & Co in Q1 2021, an estimated $4.94M increase.
  • Ingalls & Snyder LLC's biggest Q1 2021 reduction was Corcept Therapeutics, cutting an estimated $9.49M.
  • Ingalls & Snyder LLC fully exited Agenus in Q1 2021, selling an estimated $636K.
  • Ingalls & Snyder LLC's ten largest holdings make up 34% of its $2.14B portfolio in Q1 2021.
  • Ingalls & Snyder LLC opened 36 new positions and closed 23 in Q1 2021.
  • Ingalls & Snyder LLC's portfolio value rose 5.8% quarter-over-quarter to $2.14B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2021, filed 21 Apr 2021.